83 related articles for article (PubMed ID: 6749491)
21. Amino-acid sequence of activation cleavage site in plasminogen: homology with "pro" part of prothrombin.
Sottrup-Jensen L; Zajdel M; Claeys H; Petersen TE; Magnusson S
Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2577-81. PubMed ID: 1058475
[TBL] [Abstract][Full Text] [Related]
22. Isolation and renal localisation of urokinase.
Andrassy K; Ritz E
Curr Probl Clin Biochem; 1979; (9):330-41. PubMed ID: 109250
[TBL] [Abstract][Full Text] [Related]
23. Boar acrosin is a two-chain molecule. Isolation and primary structure of the light chain; homology with the pro-part of other serine proteinases.
Fock-Nüzel R; Lottspeich F; Henschen A; Müller-Esterl W
Eur J Biochem; 1984 Jun; 141(3):441-6. PubMed ID: 6378631
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.
Corti A; Nolli ML; Soffientini A; Cassani G
Thromb Haemost; 1986 Oct; 56(2):219-24. PubMed ID: 3101222
[TBL] [Abstract][Full Text] [Related]
25. Structure of mouse submaxillary gland renin.
Misono KS; Chang JJ; Inagami T
Clin Exp Hypertens A; 1983; 5(7-8):941-59. PubMed ID: 6357566
[TBL] [Abstract][Full Text] [Related]
26. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
[TBL] [Abstract][Full Text] [Related]
28. Tyrosyl residues of two molecular forms of human urinary urokinase: their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activity.
Miwa N; Sawada T; Suzuki A
Biochem Biophys Res Commun; 1982 Oct; 108(3):1136-43. PubMed ID: 6758771
[No Abstract] [Full Text] [Related]
29. Comparative studies on two active enzyme forms of human urinary urokinase. II. pH-and heat-stabilities of plasminogen activator activity.
Miwa N; Obata Y; Suzuki A
Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):472-5. PubMed ID: 7023710
[No Abstract] [Full Text] [Related]
30. Secretion of a variant of human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product.
Tsujikawa M; Okabayashi K; Morita M; Tanabe T
Yeast; 1996 May; 12(6):541-53. PubMed ID: 8771709
[TBL] [Abstract][Full Text] [Related]
31. [Isolation of a third human urokinase (S0 type)].
Doleschel W
Wien Klin Wochenschr; 1975 Apr; 87(8):282-4. PubMed ID: 1220276
[TBL] [Abstract][Full Text] [Related]
32. Characterization of radioimmunoassays for high- and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma.
Cheung T; Lui AY; Lau HK
J Lab Clin Med; 1993 Mar; 121(3):461-71. PubMed ID: 8445294
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain.
Cal S; Peinado JR; Llamazares M; Quesada V; Moncada-Pazos A; Garabaya C; López-Otín C
BMC Biochem; 2006 Mar; 7():9. PubMed ID: 16566820
[TBL] [Abstract][Full Text] [Related]
34. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
Liu JN; Tang W; Sun ZY; Kung W; Pannell R; Sarmientos P; Gurewich V
Biochemistry; 1996 Nov; 35(45):14070-6. PubMed ID: 8916892
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
[TBL] [Abstract][Full Text] [Related]
36. A high molecular weight form of human urinary urokinase.
Veronese FM; Largajolli R; Schiavon O; Casati P
Farmaco Sci; 1987 May; 42(5):319-23. PubMed ID: 3609290
[TBL] [Abstract][Full Text] [Related]
37. Relationships between structure and function of tissue-type plasminogen activator.
Rijken DC
Klin Wochenschr; 1988; 66 Suppl 12():33-9. PubMed ID: 3126346
[TBL] [Abstract][Full Text] [Related]
38. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
[No Abstract] [Full Text] [Related]
39. Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication.
Kellermann J; Lottspeich F; Henschen A; Müller-Esterl W
Eur J Biochem; 1986 Jan; 154(2):471-8. PubMed ID: 3484703
[TBL] [Abstract][Full Text] [Related]
40. Unfolding studies of the protease domain of urokinase-type plasminogen activator: the existence of partly folded states and stable subdomains.
Nowak UK; Cooper A; Saunders D; Smith RA; Dobson CM
Biochemistry; 1994 Mar; 33(10):2951-60. PubMed ID: 8130209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
